Avantor, Inc. (NYSE:AVTR) Shares Purchased by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. raised its holdings in Avantor, Inc. (NYSE:AVTR) by 4.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,952,901 shares of the company’s stock after purchasing an additional 121,810 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Avantor were worth $76,392,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in AVTR. Intech Investment Management LLC lifted its holdings in shares of Avantor by 1.8% in the 2nd quarter. Intech Investment Management LLC now owns 29,068 shares of the company’s stock valued at $616,000 after buying an additional 514 shares during the period. Arizona State Retirement System boosted its position in Avantor by 0.3% in the 2nd quarter. Arizona State Retirement System now owns 186,567 shares of the company’s stock worth $3,955,000 after purchasing an additional 528 shares in the last quarter. Veracity Capital LLC grew its stake in shares of Avantor by 1.0% during the 3rd quarter. Veracity Capital LLC now owns 52,359 shares of the company’s stock worth $1,355,000 after purchasing an additional 543 shares during the period. Wealth Enhancement Advisory Services LLC increased its holdings in shares of Avantor by 2.8% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 26,921 shares of the company’s stock valued at $571,000 after purchasing an additional 733 shares in the last quarter. Finally, US Bancorp DE lifted its stake in shares of Avantor by 6.2% in the 3rd quarter. US Bancorp DE now owns 12,615 shares of the company’s stock valued at $326,000 after purchasing an additional 734 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Avantor

In other news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares in the company, valued at $740,372.64. The trade was a 10.66 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Robert W. Baird decreased their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Wells Fargo & Company lowered their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Barclays cut their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 target price on shares of Avantor in a research report on Thursday, September 26th. Finally, UBS Group cut their price target on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a report on Tuesday, October 8th. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $27.57.

Avantor Stock Performance

AVTR opened at $21.04 on Thursday. The firm has a market capitalization of $14.32 billion, a PE ratio of 45.74, a PEG ratio of 2.56 and a beta of 1.35. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. Avantor, Inc. has a twelve month low of $19.59 and a twelve month high of $28.00. The firm’s 50-day moving average price is $23.53 and its 200 day moving average price is $23.78.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.